Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zivo Bioscience (ZIVO)

Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,144
  • Shares Outstanding, K 2,803
  • Annual Sales, $ 30 K
  • Annual Income, $ -7,780 K
  • 60-Month Beta 0.20
  • Price/Sales 655.70
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ZIVO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.59
  • Most Recent Earnings $-0.96 on 03/15/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.5500 +20.61%
on 04/29/24
8.1000 -2.47%
on 04/29/24
+0.1500 (+1.94%)
since 03/28/24
3-Month
6.2500 +26.40%
on 02/06/24
10.2100 -22.62%
on 02/21/24
-0.0100 (-0.13%)
since 01/30/24
52-Week
0.4800 +1,545.83%
on 11/29/23
19.0800 -58.60%
on 05/09/23
-9.7400 (-55.22%)
since 04/28/23

Most Recent Stories

More News
ZIVO Bioscience Receives $1 Million Bridge Financing

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
Stocks Set To Open Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.06%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.37% this morning as investors look ahead to crucial U.S. inflation data due this week for more...

ESH23 : 3,957.05s (-0.09%)
NQM24 : 17,438.25s (-0.76%)
KO : 61.93 (+0.26%)
CSCO : 46.84 (-0.30%)
PGRE : 4.62 (-0.43%)
DE : 387.50 (-1.00%)
SMIN.LN : 1,604.000 (-0.74%)
OCUL : 5.02 (+5.91%)
FIS : 67.20 (-1.06%)
ZIVO : 7.9000 (+20.61%)
APRN : 12.99 (-0.08%)
CAT : 331.07 (-1.05%)
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
ZIVO Bioscience CEO Issues Letter to Shareholders

Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today...

ZIVO : 7.9000 (+20.61%)
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
Zivo Bioscience Joins Russell Microcap® Index

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
Zivo Bioscience Joins Russell Microcap® Index

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 7.9000 (+20.61%)
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal...

ZIVO : 7.9000 (+20.61%)
ZIVO Bioscience Names Chairman John B. Payne as President and CEO

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product...

ZIVO : 7.9000 (+20.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan.

See More

Key Turning Points

3rd Resistance Point 7.9333
2nd Resistance Point 7.9267
1st Resistance Point 7.9133
Last Price 7.9000
1st Support Level 7.8933
2nd Support Level 7.8867
3rd Support Level 7.8733

See More

52-Week High 19.0800
Fibonacci 61.8% 11.9748
Fibonacci 50% 9.7800
Last Price 7.9000
Fibonacci 38.2% 7.5852
52-Week Low 0.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar